Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$23.3 million.

  • AC Immune's Free Cash Flow fell 4433.03% to -$23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.0 million, marking a year-over-year decrease of 22578.24%. This contributed to the annual value of $74.5 million for FY2024, which is 20723.4% up from last year.
  • According to the latest figures from Q3 2025, AC Immune's Free Cash Flow is -$23.3 million, which was down 4433.03% from -$19.1 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Free Cash Flow registered a high of $80.8 million during Q2 2024, and its lowest value of -$24.5 million during Q1 2022.
  • Its 5-year average for Free Cash Flow is -$11.2 million, with a median of -$17.9 million in 2023.
  • In the last 5 years, AC Immune's Free Cash Flow skyrocketed by 61789.04% in 2024 and then plummeted by 154867.88% in 2025.
  • AC Immune's Free Cash Flow (Quarter) stood at -$24.3 million in 2021, then rose by 15.12% to -$20.6 million in 2022, then grew by 2.55% to -$20.1 million in 2023, then soared by 127.71% to $5.6 million in 2024, then plummeted by 518.57% to -$23.3 million in 2025.
  • Its Free Cash Flow stands at -$23.3 million for Q3 2025, versus -$19.1 million for Q2 2025 and -$21.1 million for Q1 2025.